Great post by Adam Kroetsch on the FDA’s recent announcement of “real time clinical trials”.
The idea of streamlining data collection and review sounds very promising in theory, but he argues the FDA needs to go beyond pilots to actually change practice, and shares some recommendations for how they can do so.